Arielle Butts, Ph.D.
Affiliations: | 2013 | School of Arts and Sciences | University of Rochester, Rochester, NY |
Area:
Molecular Chemistry, Microbiology Biology, Organic ChemistryGoogle:
"Arielle Butts"Parents
Sign in to add mentor| Damian Krysan | grad student | 2013 | Rochester | |
| (Repurposing Triphenylethylene Estrogen Receptor Antagonists as Anticryptococcal Agents.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Njikan S, Ahmed S, Manning A, et al. (2022) Chemical Exploration of a Highly Selective Scaffold with Activity against Intracellular . Microbiology Spectrum. e0116122 |
| Butts A, Reitler P, Nishimoto AT, et al. (2019) A systematic screen reveals a diverse collection of medications induce antifungal resistance in species. Antimicrobial Agents and Chemotherapy |
| Luna-Tapia A, Butts A, Palmer GE. (2018) Loss of C-5 sterol desaturase activity in - azole resistance or merely trailing growth? Antimicrobial Agents and Chemotherapy |
| Butts A, Reitler P, Ge W, et al. (2018) Commonly used oncology drugs decrease antifungal effectiveness against and species. Antimicrobial Agents and Chemotherapy |
| Butts A, DeJarnette C, Peters TL, et al. (2017) Target Abundance-Based Fitness Screening (TAFiS) Facilitates Rapid Identification of Target-Specific and Physiologically Active Chemical Probes. Msphere. 2 |
| Butts A, Palmer GE, Rogers PD. (2016) Antifungal adjuvants: preserving and extending the antifungal arsenal. Virulence. 0 |
| Butts A, Martin JA, DiDone L, et al. (2015) Structure-activity relationships for the antifungal activity of selective estrogen receptor antagonists related to tamoxifen. Plos One. 10: e0125927 |
| Brown JC, Nelson J, VanderSluis B, et al. (2014) Unraveling the biology of a fungal meningitis pathogen using chemical genetics. Cell. 159: 1168-87 |
| Butts A, Koselny K, Chabrier-Roselló Y, et al. (2014) Estrogen receptor antagonists are anti-cryptococcal agents that directly bind EF hand proteins and synergize with fluconazole in vivo. Mbio. 5: e00765-13 |
| Butts A, DiDone L, Koselny K, et al. (2013) A repurposing approach identifies off-patent drugs with fungicidal cryptococcal activity, a common structural chemotype, and pharmacological properties relevant to the treatment of cryptococcosis. Eukaryotic Cell. 12: 278-87 |